Mesa Laboratories Inc /Co/ (NASDAQ: MLAB)

Mesa Laboratories, Inc., a Colorado-based corporation, operates under the ticker symbol MLAB in the life sciences tools and critical quality control solutions industry. The company is a global leader in the design and manufacture of products and services for regulated applications in the pharmaceutical, healthcare, and medical device industries.

Mesa Laboratories operates in four segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. The Clinical Genomics segment develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services for research applications. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. Lastly, the Calibration Solutions segment develops, manufactures, and sells quality control products for applications such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing.

The company generates revenue through the sale of products and services, including consumables, hardware, and testing services. In the Sterilization and Disinfection Control segment, Mesa Laboratories offers a variety of product formats, including inoculated carriers, self-contained indicators, process challenge devices, and growth media. In the Clinical Genomics segment, the MassARRAY system is a proprietary technology that uses mass spectrometry to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other highly differentiated applications. In the Biopharmaceutical Development segment, the segment's protein analysis solutions enable the detection and quantification of a target protein in a biological or bioprocess sample, and the segment's peptide synthesis solutions enable customers to automate the chemical synthesis of peptides used in various applications.

Mesa Laboratories is a leader in its respective markets, with a strong competitive position in North America and a growing presence in international markets. The company's products are used by leading pharmaceutical and biotechnology companies, as well as by hospitals, medical device manufacturers, and contract research organizations. The company's reputation for quality and reliability, and its products' accuracy, precision, and ease of use give Mesa Laboratories a competitive advantage.

In terms of research and development, Mesa Laboratories focuses on developing new products and technologies that meet the evolving needs of its customers. The company has a global presence, with manufacturing facilities in the United States, Europe, and Asia, and a strong distribution network that reaches customers around the world.